If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: BUSINESS WIRE
Press Release: Hatchtech : Hatchtech Announces Successful Phase 3 Study Results for Xeglyze™ Lotion
MELBOURNE, Australia--(BUSINESS WIRE)--Specialty pharmaceutical company Hatchtech today announced positive results from its two pivotal Phase 3 clinical studies evaluating Xeglyze™ Lotion as a potential treatment for head lice infestation.
Read full article »
Hatchtech's Competitors
|
Hatchtech's News
|
Hatchtech's Financials
Follow
Followers on Owler
2
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO
Hugh Alsop
CEO Approval Rating
68/100
Weigh In
Hatchtech develops head lice treatment products.
Read more
See Hatchtech company profile »
